Company Filing History:
Years Active: 2025
Title: Zhiwen Long: Innovator in Cancer Treatment
Introduction
Zhiwen Long is a notable inventor based in Sichuan, China. He has made significant contributions to the field of cancer treatment through his innovative research and patenting efforts. His work focuses on dietary interventions that may aid in cancer therapy.
Latest Patents
Zhiwen Long holds a patent titled "Dietary glycine and serine restriction for cancer treatment." This patent provides a food composition that includes a variety of amino acids or their salts. Specifically, it comprises about 0.0016-0.6 wt % of glycine or its salt and about 0.00109-1.2 wt % of serine or its salt. The patent also outlines a method for treating cancer by partially or completely substituting the normal diet of a subject with this food composition. Additionally, it suggests the option of administering a therapeutically effective amount of an anti-PD-1 antibody or an anti-PD-L1 antibody.
Career Highlights
Zhiwen Long is associated with Rplushealth Limited, where he continues to develop and refine his innovative ideas. His work is pivotal in exploring new dietary approaches to cancer treatment, which could potentially improve patient outcomes.
Collaborations
Zhiwen Long collaborates with notable colleagues, including Xuelei Ma and Chengyuan He. Their combined expertise contributes to the advancement of research in the field of cancer treatment.
Conclusion
Zhiwen Long's innovative approach to cancer treatment through dietary modifications showcases the potential of combining nutrition with medical therapies. His patent reflects a significant step forward in the quest for effective cancer treatments.